Fine Organic Industries Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Fine Organic Industries Limited (NSE:FINEORG) just released its latest quarterly results and things are looking bullish. It was a solid earnings report, with revenues and statutory earnings per share (EPS) both coming in strong. Revenues were 13% higher than the analysts had forecast, at ₹6.9b, while EPS were ₹45.06 beating analyst models by 36%. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
After the latest results, the eleven analysts covering Fine Organic Industries are now predicting revenues of ₹26.2b in 2027. If met, this would reflect an okay 6.8% improvement in revenue compared to the last 12 months. Per-share earnings are expected to increase 4.4% to ₹149. Yet prior to the latest earnings, the analysts had been anticipated revenues of ₹25.3b and earnings per share (EPS) of ₹136 in 2027. So there seems to have been a moderate uplift in sentiment following the latest results, given the upgrades to both revenue and earnings per share forecasts for next year.
Check out our latest analysis for Fine Organic Industries
Despite these upgrades,the analysts have not made any major changes to their price target of ₹5,337, suggesting that the higher estimates are not likely to have a long term impact on what the stock is worth. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. Currently, the most bullish analyst values Fine Organic Industries at ₹6,357 per share, while the most bearish prices it at ₹4,009. These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.
These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Fine Organic Industries' past performance and to peers in the same industry. The analysts are definitely expecting Fine Organic Industries' growth to accelerate, with the forecast 9.2% annualised growth to the end of 2027 ranking favourably alongside historical growth of 4.6% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 12% per year. So it's clear that despite the acceleration in growth, Fine Organic Industries is expected to grow meaningfully slower than the industry average.
The Bottom Line
The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Fine Organic Industries following these results. They also upgraded their revenue estimates for next year, even though it is expected to grow slower than the wider industry. The consensus price target held steady at ₹5,337, with the latest estimates not enough to have an impact on their price targets.
With that in mind, we wouldn't be too quick to come to a conclusion on Fine Organic Industries. Long-term earnings power is much more important than next year's profits. We have estimates - from multiple Fine Organic Industries analysts - going out to 2029, and you can see them free on our platform here.
You can also see our analysis of Fine Organic Industries' Board and CEO remuneration and experience, and whether company insiders have been buying stock.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.